Home > Insider Trading > Filing (0001493152-23-011239)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1412486	Cocrystal Pharma Inc.	COCP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
898860	Al Et Md Phillip Frost	4400 Biscayne Blvd. Miami FL 33137		Yes	No	Yes	No
1380896	Trust Investments Gamma Frost	4400 Biscayne Blvd. Miami FL 33137		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-04	1,015,229	$1.97	1,319,838	No	4	P	Indirect	By Frost Gamma Investments Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Frost Gamma Investments Trust

Footnotes

These securities were purchased in a private transaction with the Issuer.
The amount of securities beneficially owned has been adjusted for the one-for-12 reverse stock split effective October 11, 2022.
These securities are held by Frost Gamma Investments Trust, of which Phillip Frost, MD (the "Reporting Person") is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. The Reporting Person is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.